“Saying the new H1N1 [swine flu] virus is ‘unstoppable’, the WHO gave drug makers a full go-ahead to manufacture vaccines against the pandemic influenza strain on Monday and said healthcare workers should be the first to get one,” Reuters reports (Fox, 7/14). This, as “Britain, Brazil, Colombia, Mexico, the Philippines…
HHS Secretary Kathleen Sebelius said Sunday the U.S. has agreed to put an addition $1 billion towards ingredients for the production of a vaccine that offers protection against the H1N1 (swine flu) virus, Reuters reports.
The Obama administration on Thursday said a nationwide vaccination program could begin as early as mid-October to protect Americans from the H1N1 (swine flu) virus and pledged $350 million to help prepare communities across the country for this effort, the Washington Times reports.
“The White House, months before flu season, will roll out the big guns Thursday for a swine flu preparedness summit, underscoring the importance the Obama administration is placing on the pandemic,” CNN reports.
Within the next few days, the WHO “will recommend that countries stop trying to test all suspected cases of swine flu, said Keiji Fukuda, the agencyâ€™s assistant director-general of health security and environment,” Tuesday during a conference call with reporters, Bloomberg reports.
Developing countries will need an estimated $1 billion by year’s end to ensure their access to antivirals and vaccines to protect against the H1N1 (swine flu) virus, U.N. Secretary General Ban Ki-moon said Monday, AFP/Google.com reports.
WHO leaders and international health ministers met Thursday for a two-day meeting in Cancun, Mexico, to share the lessons learned from the spread of H1N1 (swine flu) (Xinhua, 7/3) and strategies for “battling the pandemic,” the AP/Washington Post reports.
The vaccine manufacturer Roche on Wednesday announced a program to help ensure developing countries have access to its antiviral Tamiflu, for “the management of a novel influenza strain defined by the WHO as having significant and current pandemic potential,” Reuters reports.
A spokesperson from the vaccine manufacturer Roche confirmed reports Monday that a Denmark patient with H1N1 (swine flu) developed resistance to the antiviral Tamiflu, a drug known to decrease the spread and severity of the virus, Reuters reports.
The CDC convened a national vaccine advisory committee Friday to discuss the best response to the spread of H1N1 (swine flu) with an estimated 6,000 new cases in the U.S. last week alone, Reuters reports.